CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)

CMG Pharmaceutical Statistics

Total Valuation

KOSDAQ:058820 has a market cap or net worth of KRW 252.51 billion. The enterprise value is 260.61 billion.

Market Cap	252.51B
Enterprise Value	260.61B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:058820 has 147.84 million shares outstanding. The number of shares has decreased by -0.52% in one year.

Current Share Class	147.84M
Shares Outstanding	147.84M
Shares Change (YoY)	-0.52%
Shares Change (QoQ)	+2.62%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	3.64%
Float	109.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.67
PB Ratio	1.28
P/TBV Ratio	1.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-14.48
EV / Sales	2.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.35

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.36.

Current Ratio	1.35
Quick Ratio	0.97
Debt / Equity	0.36
Debt / EBITDA	n/a
Debt / FCF	-2.82
Interest Coverage	-1.16

Financial Efficiency

Return on equity (ROE) is -9.10% and return on invested capital (ROIC) is -1.33%.

Return on Equity (ROE)	-9.10%
Return on Assets (ROA)	-1.18%
Return on Invested Capital (ROIC)	-1.33%
Return on Capital Employed (ROCE)	-2.51%
Revenue Per Employee	424.78M
Profits Per Employee	-80.72M
Employee Count	223
Asset Turnover	0.34
Inventory Turnover	1.65

Taxes

Income Tax	-2.35B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.62% in the last 52 weeks. The beta is 0.73, so KOSDAQ:058820's price volatility has been lower than the market average.

Beta (5Y)	0.73
52-Week Price Change	-19.62%
50-Day Moving Average	1,856.08
200-Day Moving Average	1,999.83
Relative Strength Index (RSI)	31.97
Average Volume (20 Days)	706,135

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:058820 had revenue of KRW 94.73 billion and -18.00 billion in losses. Loss per share was -128.75.

Revenue	94.73B
Gross Profit	49.69B
Operating Income	-5.34B
Pretax Income	-20.35B
Net Income	-18.00B
EBITDA	-1.93B
EBIT	-5.34B
Loss Per Share	-128.75

Balance Sheet

The company has 62.90 billion in cash and 71.00 billion in debt, giving a net cash position of -8.09 billion or -54.73 per share.

Cash & Cash Equivalents	62.90B
Total Debt	71.00B
Net Cash	-8.09B
Net Cash Per Share	-54.73
Equity (Book Value)	197.06B
Book Value Per Share	1,338.54
Working Capital	33.63B

Cash Flow

In the last 12 months, operating cash flow was -3.58 billion and capital expenditures -21.61 billion, giving a free cash flow of -25.19 billion.

Operating Cash Flow	-3.58B
Capital Expenditures	-21.61B
Free Cash Flow	-25.19B
FCF Per Share	-170.35

Margins

Gross margin is 52.45%, with operating and profit margins of -5.64% and -19.00%.

Gross Margin	52.45%
Operating Margin	-5.64%
Pretax Margin	-21.48%
Profit Margin	-19.00%
EBITDA Margin	-2.03%
EBIT Margin	-5.64%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:058820 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.52%
Shareholder Yield	0.52%
Earnings Yield	-7.13%
FCF Yield	-9.97%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 28, 2007. It was a forward split with a ratio of 2.

Last Split Date	Aug 28, 2007
Split Type	Forward
Split Ratio	2

Scores

KOSDAQ:058820 has an Altman Z-Score of 1.97 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.97
Piotroski F-Score	3